The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum.

Rachel A BernierSarah J BanksMatthew S PanizzonMurray J AndrewsEmily G JacobsDouglas R GalaskoAlyx L ShepherdKaterina AkassoglouErin E Sundermannnull null

Published in: Alzheimer's & dementia (Amsterdam, Netherlands) (2022)

Women may be more susceptible than men to the adverse effects of sTNFR2 on cognition with a potential etiological link with tau to these effects.

Keyphrases

polycystic ovary syndrome
mild cognitive impairment
pregnancy outcomes
cerebrospinal fluid
white matter
cognitive decline
cervical cancer screening
breast cancer risk
multiple sclerosis
middle aged
risk assessment